Innovations in Pulmonary Embolism Treatment Devices
Pulmonary embolism (PE) remains a significant cardiovascular concern, often leading to serious complications if not promptly and effectively managed. While anticoagulation remains a cornerstone of therapy, advancements in medical device technology are revolutionizing the treatment landscape, offering less invasive and more targeted approaches for thrombus removal. These innovations are particularly crucial for patients with intermediate-risk PE, where rapid thrombus debulking can significantly improve outcomes and reduce the risk of long-term complications.
One such innovation is the **FlowTriever System** by Inari Medical. This mechanical thrombectomy system was the first to receive FDA 510(k) clearance specifically for the treatment of pulmonary embolism. The FlowTriever system is designed for rapid thrombus removal and immediate symptom improvement. Its large-bore aspiration technology allows for efficient clot extraction without the need for thrombolytic drugs, thereby minimizing the risk of bleeding complications associated with systemic thrombolysis. Clinical data from the FLASH Registry, a large prospective study, has demonstrated the system's procedural safety and effectiveness, showing low rates of major adverse events and significant improvements in cardiac function and dyspnea at follow-up [1].
Another notable advancement is the **AVENTUS Thrombectomy System** by Inquis Medical, Inc. This fully integrated, next-generation mechanical thrombectomy device combines a catheter, aspiration syringe, and a blood filtration chamber into a single unit. The AVENTUS system aims to enhance ease of use and procedural efficiency by integrating dilator and navigation tools, reducing the need for multiple wire and catheter exchanges. Its design facilitates uninterrupted aspiration and blood filtration, securely capturing clots and streamlining the thrombus removal process. Currently undergoing evaluation in the AVENTUS Pivotal IDE Study, this system holds promise for setting a new standard in streamlined thrombus removal [2].
The **Symphony Thrombectomy System** by Imperative Care, Inc., represents another significant leap forward. This novel, next-generation continuous aspiration system features full vacuum control, addressing limitations and workflow inefficiencies often associated with manual aspiration methods. The Symphony system incorporates large-bore aspiration catheters (16F and 24F) and allows for mechanical clot engagement with the ProHelix, enabling efficient thrombus removal from both main and segmental pulmonary arteries. The SYMPHONY-PE trial has supported the safety and effectiveness of this system in patients with acute intermediate-risk pulmonary embolism, demonstrating significant improvements in right ventricle-to-left ventricle ratio and pulmonary artery pressures with a favorable safety profile [3].
Furthermore, the **EKOS Endovascular System** by Boston Scientific has established itself as a leading interventional device for PE treatment. Utilizing ultrasound technology in conjunction with clot-dissolving drugs, EKOS unwinds and thins fibrin strands, exposing more drug receptor sites and driving the drug deeper into the clot. This approach allows for targeted thrombolysis with significantly lower lytic dosing compared to systemic administration, thereby reducing bleeding risks. The EKOS system has a proven history of safety and efficacy, with extensive clinical evidence supporting its use in improving patient outcomes [4].
These innovative devices underscore a paradigm shift in pulmonary embolism management, moving towards more direct, efficient, and safer interventions. While these technologies offer promising avenues for treatment, it is crucial to remember that medical decisions should always be made in consultation with qualified healthcare professionals. This information is for academic purposes only and does not constitute medical advice.
References
[1] Inari Medical. *FlowTriever® system for the treatment of pulmonary embolism (PE)*. Available at: [https://www.inarimedical.com/flowtriever-system](https://www.inarimedical.com/flowtriever-system) [2] Endovascular Today. *AVENTUS Thrombectomy System: Innovative Endovascular Solution for Pulmonary Embolism*. Available at: [https://evtoday.com/articles/2024-nov/aventus-thrombectomy-system-innovative-endovascular-solution-for-pulmonary-embolism](https://evtoday.com/articles/2024-nov/aventus-thrombectomy-system-innovative-endovascular-solution-for-pulmonary-embolism) [3] AHA Journals. *Prospective Multicenter IDE Study of the Next-Generation Precision Aspiration Thrombectomy System for Intermediate-Risk Pulmonary Embolism: The SYMPHONY-PE Trial*. Available at: [https://www.ahajournals.org/doi/10.1161/CIRCINTERVENTIONS.125.015815](https://www.ahajournals.org/doi/10.1161/CIRCINTERVENTIONS.125.015815) [4] Boston Scientific. *PE Treatment Technology -EKOS Endovascular System*. Available at: [https://www.bostonscientific.com/en-US/medical-specialties/vascular-surgery/ekos-endovascular-system/pe-treatment-technology.html](https://www.bostonscientific.com/en-US/medical-specialties/vascular-surgery/ekos-endovascular-system/pe-treatment-technology.html)